IBDEI10L ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16312,1,3,0)
 ;;=3^Bladder Disorders,Other Spec
 ;;^UTILITY(U,$J,358.3,16312,1,4,0)
 ;;=4^N32.89
 ;;^UTILITY(U,$J,358.3,16312,2)
 ;;=^87989
 ;;^UTILITY(U,$J,358.3,16313,0)
 ;;=N33.^^88^876^6
 ;;^UTILITY(U,$J,358.3,16313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16313,1,3,0)
 ;;=3^Bladder Disorders,Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,16313,1,4,0)
 ;;=4^N33.
 ;;^UTILITY(U,$J,358.3,16313,2)
 ;;=^5015654
 ;;^UTILITY(U,$J,358.3,16314,0)
 ;;=N34.2^^88^876^113
 ;;^UTILITY(U,$J,358.3,16314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16314,1,3,0)
 ;;=3^Urethritis
 ;;^UTILITY(U,$J,358.3,16314,1,4,0)
 ;;=4^N34.2
 ;;^UTILITY(U,$J,358.3,16314,2)
 ;;=^88231
 ;;^UTILITY(U,$J,358.3,16315,0)
 ;;=N34.1^^88^876^114
 ;;^UTILITY(U,$J,358.3,16315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16315,1,3,0)
 ;;=3^Urethritis,Nonspec
 ;;^UTILITY(U,$J,358.3,16315,1,4,0)
 ;;=4^N34.1
 ;;^UTILITY(U,$J,358.3,16315,2)
 ;;=^5015655
 ;;^UTILITY(U,$J,358.3,16316,0)
 ;;=N39.0^^88^876^118
 ;;^UTILITY(U,$J,358.3,16316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16316,1,3,0)
 ;;=3^Urinary Tract Infection,Site Not Spec
 ;;^UTILITY(U,$J,358.3,16316,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,16316,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,16317,0)
 ;;=N31.0^^88^876^79
 ;;^UTILITY(U,$J,358.3,16317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16317,1,3,0)
 ;;=3^Neuropathic Bladder,Uninhibited NEC
 ;;^UTILITY(U,$J,358.3,16317,1,4,0)
 ;;=4^N31.0
 ;;^UTILITY(U,$J,358.3,16317,2)
 ;;=^5015644
 ;;^UTILITY(U,$J,358.3,16318,0)
 ;;=R31.9^^88^876^58
 ;;^UTILITY(U,$J,358.3,16318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16318,1,3,0)
 ;;=3^Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,16318,1,4,0)
 ;;=4^R31.9
 ;;^UTILITY(U,$J,358.3,16318,2)
 ;;=^5019328
 ;;^UTILITY(U,$J,358.3,16319,0)
 ;;=R31.0^^88^876^55
 ;;^UTILITY(U,$J,358.3,16319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16319,1,3,0)
 ;;=3^Hematuria,Gross
 ;;^UTILITY(U,$J,358.3,16319,1,4,0)
 ;;=4^R31.0
 ;;^UTILITY(U,$J,358.3,16319,2)
 ;;=^5019325
 ;;^UTILITY(U,$J,358.3,16320,0)
 ;;=R31.1^^88^876^54
 ;;^UTILITY(U,$J,358.3,16320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16320,1,3,0)
 ;;=3^Hematuria,Benign Essential Microscopic
 ;;^UTILITY(U,$J,358.3,16320,1,4,0)
 ;;=4^R31.1
 ;;^UTILITY(U,$J,358.3,16320,2)
 ;;=^5019326
 ;;^UTILITY(U,$J,358.3,16321,0)
 ;;=N40.0^^88^876^3
 ;;^UTILITY(U,$J,358.3,16321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16321,1,3,0)
 ;;=3^BPH w/o Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,16321,1,4,0)
 ;;=4^N40.0
 ;;^UTILITY(U,$J,358.3,16321,2)
 ;;=^5015689
 ;;^UTILITY(U,$J,358.3,16322,0)
 ;;=N40.1^^88^876^2
 ;;^UTILITY(U,$J,358.3,16322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16322,1,3,0)
 ;;=3^BPH w/ Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,16322,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,16322,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,16323,0)
 ;;=N41.0^^88^876^89
 ;;^UTILITY(U,$J,358.3,16323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16323,1,3,0)
 ;;=3^Prostatitis,Acute
 ;;^UTILITY(U,$J,358.3,16323,1,4,0)
 ;;=4^N41.0
 ;;^UTILITY(U,$J,358.3,16323,2)
 ;;=^259106
 ;;^UTILITY(U,$J,358.3,16324,0)
 ;;=N45.1^^88^876^31
 ;;^UTILITY(U,$J,358.3,16324,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16324,1,3,0)
 ;;=3^Epididymitis
 ;;^UTILITY(U,$J,358.3,16324,1,4,0)
 ;;=4^N45.1
